Missed opportunities for NCD multimorbidity prevention in adolescents and youth living with HIV in urban South Africa

Monika Kamkuemah, Blessings Gausi, Tolu Oni, Monika Kamkuemah, Blessings Gausi, Tolu Oni

Abstract

Background: Epidemiological transition in high HIV-burden settings is resulting in a rise in HIV/NCD multimorbidity. The majority of NCD risk behaviours start during adolescence, making this an important target group for NCD prevention and multimorbidity prevention in adolescents with a chronic condition such as HIV. However, there is data paucity on NCD risk and prevention in adolescents with HIV in high HIV-burden settings. The aim of this study was to investigate the extent to which NCD comorbidity (prevention, diagnosis, and management) is incorporated within existing adolescent HIV primary healthcare services in Cape Town, South Africa.

Methods: We reviewed medical records of 491 adolescents and youth living with HIV (AYLHIV) aged 10-24 years across nine primary care facilities in Cape Town from November 2018-March 2019. Folders were systematically sampled from a master list of all AYLHIV per facility and information on HIV management and care, NCDs, NCD risk and NCD-related health promotion extracted.

Results: The median age was 20 years (IQR: 14-23); median age at ART initiation 18 years (IQR: 6-21) and median duration on ART 3 years (IQR: 1.1-8.9). Fifty five percent of participants had a documented comorbidity, of which 11% had an NCD diagnosis with chronic respiratory diseases (60%) and mental disorders (37%) most common. Of those with documented anthropometrics (62%), 48% were overweight or obese. Fifty nine percent of participants had a documented blood pressure, of which 27% were abnormal. Twenty-six percent had a documented health promoting intervention, 42% of which were NCD-related; ranging from alcohol or substance abuse (13%); smoking (9%); healthy weight or diet (9%) and mental health counselling (10%).

Conclusions: Our study demonstrates limited NCD screening and health promotion in AYLHIV accessing healthcare services. Where documented, our data demonstrates existing NCD comorbidity and NCD risk factors highlighting a missed opportunity for multimorbidity prevention through NCD screening and health promotion. Addressing this missed opportunity requires an integrated health system and intersectoral action on upstream NCD determinants to turn the tide on the rising NCD and multimorbidity epidemic.

Keywords: Adolescents; HIV; Multimorbidity; Non-communicable Disease; Youth.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Study population and sampling methodology across sub-districts

References

    1. Benziger CP, Roth GA, Moran AE. The global burden of disease study and the preventable burden of NCD. Glob Heart. 2016;11(4):393–397.
    1. World Health Organization . Noncommunicable diseases. 2014.
    1. World Health Organization. Global status report on noncommunicable diseases 2014. Geneva: World Health Organisation; 2014. . Accessed 03 Oct 2019.
    1. Abubakar I, Tillmann T, Banerjee A. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385(9963):117–171.
    1. Forouzanfar MH, Afshin A, Alexander LT, Anderson HR, Bhutta ZA, Biryukov S, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2016;388(10053):1659–1724.
    1. Santosa A, Wall S, Fottrell E, Högberg U, Byass P. The development and experience of epidemiological transition theory over four decades: a systematic review. Glob Health Action. 2014;7:1.
    1. Oni T, Unwin N. Why the communicable/non-communicable disease dichotomy is problematic for public health control strategies: implications of multimorbidity for health systems in an era of health transition. Int Health. 2015;7(6):390.
    1. Daniels ME, Donilon TE, Bollyky TJ. Council on Foreign Relations independent task force report. 2014. The emerging global health crisis: noncommunicable diseases in low-and middle-income countries.
    1. Atun R, Davies JI, Gale EA, Bärnighausen T, Beran D, Kengne AP, et al. Diabetes in sub-Saharan Africa: from clinical care to health policy. Lancet Diabetes Endocrinol. 2017;5(8):622–667. doi: 10.1016/S2213-8587(17)30181-X.
    1. World Bank . The growing danger of non-communicable diseases: acting now to reverse course. Conference paper: 2011. 2011.
    1. Darnton-Hill I, Nishida C, James WP. A life course approach to diet, nutrition and the prevention of chronic diseases. Public Health Nutr. 2004;7(1a):101–121.
    1. World Health Organization . Health needs of adolescents: report of a WHO expert committee. WHO Technical Report Series. 1977.
    1. World Health Organization . The second decade: improving adolescent health and development. Geneva: World Health Organization; 2001.
    1. Steinberg L. Risk taking in adolescence: what changes, and why? Ann N Y Acad Sci. 2004;1021(1):51–58.
    1. Patton GC, McMorris BJ, Toumbourou JW, Hemphill SA, Donath S, Catalano RF. Puberty and the onset of substance use and abuse. Pediatrics. 2004;114(3):e300–e306.
    1. Steinberg L, Morris AS. Adolescent development. J Cogn Educ Psychol. 2001;2(1):55–87.
    1. Sheehan P, Sweeny K, Rasmussen B, Wils A, Friedman HS, Mahon J, et al. Building the foundations for sustainable development: a case for global investment in the capabilities of adolescents. Lancet. 2017;390(10104):1792–1806.
    1. Hervish A, Clifton D. The status report on adolescents and young people in sub-Saharan Africa: opportunities and challenges. Washington, DC: Population Reference Bureau; 2012.
    1. Currie C, Gabhainn SN, Godeau E, Committee IHNC. The health behaviour in school-aged children: WHO collaborative cross-national (HBSC) study: origins, concept, history and development 1982–2008. Int J Public Health. 2009;54(2):131–139.
    1. Arrazola RA, Ahluwalia IB, Pun E, de Quevedo IG, Babb S, Armour BS. Current tobacco smoking and desire to quit smoking among students aged 13–15 years—global youth tobacco survey, 61 countries, 2012–2015. MMWR Morb Mortal Wkly Rep. 2017;66(20):533.
    1. World Health Organisation. Global status report on alcohol and health, 2014. Geneva: World Health Organization; 2014. . Accessed 24 Sept 2019.
    1. Azzopardi P. Adolescent health comes of age. Lancet. 2012;379(9826):1583–1584.
    1. Nakagawa F, May M, Phillips A. Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis. 2013;26(1):17–25.
    1. Wandeler G, Johnson LF, Egger M. Trends in life expectancy of HIV-positive adults on ART across the globe: comparisons with general population. Curr Opin HIV AIDS. 2016;11(5):492.
    1. Oni T, Youngblood E, Boulle A, McGrath N, Wilkinson RJ, Levitt NS. Patterns of HIV, TB, and non-communicable disease multi-morbidity in peri-urban South Africa- a cross sectional study. BMC Infect Dis. 2015;15:20.
    1. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med. 2011;62:141.
    1. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382(9903):1525–1533.
    1. Dillon DG, Gurdasani D, Riha J, Ekoru K, Asiki G, Mayanja BN, et al. Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. Int J Epidemiol. 2013;42(6):1754–1771.
    1. Thienemann F, Sliwa K, Rockstroh JK. HIV and the heart: the impact of antiretroviral therapy: a global perspective. Eur Heart J. 2013;34(46):3538–3546.
    1. Madeddu G, Fois A, Calia G, Babudieri S, Soddu V, Becciu F, et al. Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? Infection. 2013;41(2):347–353.
    1. Freiberg MS, Chang C-CH, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173(8):614–622.
    1. Crothers K, Butt AA, Gibert CL, Rodriguez-Barradas MC, Crystal S, Justice AC. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest J. 2006;130(5):1326–1333.
    1. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92(7):2506–2512.
    1. Achwoka D, Waruru A, Chen T-H, Masamaro K, Ngugi E, Kimani M, et al. Noncommunicable disease burden among HIV patients in care: a national retrospective longitudinal analysis of HIV-treatment outcomes in Kenya, 2003-2013. BMC Public Health. 2019;19(1):372.
    1. Kwarisiima D, Balzer L, Heller D, Kotwani P, Chamie G, Clark T, et al. Population-based assessment of hypertension epidemiology and risk factors among HIV-positive and general populations in rural Uganda. PLoS One. 2016;11:5.
    1. McComsey GA, Tebas P, Shane E, Yin MT, Overton ET, Huang JS, et al. Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis. 2010;51(8):937–946.
    1. Reid A, Stöhr W, Walker AS, Williams IG, Kityo C, Hughes P, et al. Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. Clin Infect Dis. 2008;46(8):1271–1281.
    1. Butt AA, McGinnis K, Rodriguez-Barradas MC, Crystal S, Simberkoff M, Goetz MB, et al. HIV infection and the risk of diabetes mellitus. AIDS (London, England) 2009;23(10):1227.
    1. Ammassari A, Antinori A, Aloisi MS, Trotta MP, Murri R, Bartoli L, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics. 2004;45(5):394–402.
    1. Miller T, Wang J, Jacobson D, Takemoto J, Sharma T, Geffner M, et al. Mitochondrial function and metabolic abnormalities in children with perinatally-aquired HIV infection in the pediatric HIV/AIDS cohort study (PHACS) J Int AIDS Soc. 2012;15:69–70.
    1. Miller TL, Borkowsky W, DiMeglio LA, Dooley L, Geffner ME, Hazra R, et al. Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children. HIV Med. 2012;13(5):264–275.
    1. Lowenthal ED, Bakeera-Kitaka S, Marukutira T, Chapman J, Goldrath K, Ferrand RA. Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challenges. Lancet Infect Dis. 2014;14(7):627–639.
    1. Joint United Nations Programme on HIV/AIDS, Joint United Nations Programme on HIV/AIDS . UNAIDS, data 2017. Geneva: UNAIDS; 2017.
    1. Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D. The burden of non-communicable diseases in South Africa. Lancet. 2009;374(9693):934–947.
    1. UNICEF. Key HIV epidemiology indicators for children and adolescents aged 0–19, 2000–2018. . Accessed 24 September 2019.
    1. Baker R, Taylor E, Essafi S, Jarvis JD, Odok C. Engaging young people in the prevention of noncommunicable diseases. Bull World Health Organ. 2016;94(7):484.
    1. Hazra R, Siberry GK, Mofenson LM. Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection*. Annu Rev Med. 2010;61:169–185.
    1. Joint United Nations Programme on HIV/AIDS . Chronic care of HIV and non-communicable diseases: how to leverage the HIV experience. 2011.
    1. Asmall S, Mahomed O. Integrated chronic disease management manual. Pretoria: Department of Health; 2013.
    1. Kawonga M, Fonn S, Blaauw D. Administrative integration of vertical HIV monitoring and evaluation into health systems: a case study from South Africa. Glob Health Action. 2013;6(1):19252.
    1. Innes S, Patel K. Noncommunicable diseases in adolescents with perinatally acquired HIV-1 infection in high-income and low-income settings. Curr Opin HIV AIDS. 2018;13(3):187–195.
    1. Statistics South Africa . Mid-year population estimates 2018. Report P0302 Pretoria: Statistics South Africa. 2018.
    1. Western Cape Government Health Department . Annual performance plan 2016–2017. 2016.
    1. Cape Metro Health District . Cape Metro District health plan 2018/19–2020/21. Cape Town: District Management Team; 2018.
    1. Western Cape Government: 2016 Socio-economic Profile: City of Cape Town. Department of Social Development. Cape Town; 2016. . Accessed 03 Oct 2019.
    1. Statistics South Africa . Mortality and causes of death in South Africa, 2016: findings from death notification. 2018.
    1. National Department of Health, editor. The 2015 National Antenatal Sentinel HIV & Syphilis Survey, South Africa, National Department of health. Pretoria: Edited by National Department of Health; 2017.
    1. National Department of Health, editor. The 2012 National Antenatal Sentinel HIV & Herpes Simplex Type-2 prevalence survey in South Africa. Pretoria: Edited by National Department of Health; 2014.
    1. Shisana O. The South African National Health and Nutrition Examination Survey: SANHANES-1: HSRC press; 2013.
    1. de Bruin SR, Versnel N, Lemmens LC, Molema CCM, Schellevis FG, Nijpels G, et al. Comprehensive care programs for patients with multiple chronic conditions: a systematic literature review. Health Policy. 2012;107(2–3):108–145.
    1. Nuño R, Coleman K, Bengoa R, Sauto R. Integrated care for chronic conditions: the contribution of the ICCC framework. Health Policy. 2012;105(1):55–64.
    1. Ameh S, Klipstein-Grobusch K, Musenge E, Kahn K, Tollman S, Gomez-Olive FX. Effectiveness of an integrated approach to HIV and hypertension Care in Rural South Africa: controlled interrupted time-series analysis. J Acquir Immune Defic Syndr. 2017;75(4):472–479.
    1. Ameh S, Klipstein-Grobusch K, D’ambruoso L, Kahn K, Tollman SM, Gómez-Olivé FX. Quality of integrated chronic disease care in rural South Africa: user and provider perspectives. Health Policy Plan. 2017;32(2):257–266.
    1. Chatterton-Kirchmeier S, Camacho-Gonzalez AF, McCracken CE, Chakraborty R, Batisky DL: Increased prevalence of elevated blood pressures in HIV-infected children, adolescents and young adults. Pediatr Infect Dis J. 2015;34(6):610–14.
    1. Reddy S, James S, Sewpaul R, Sifunda S, Ellahebokus A, Kambaran NS, Omardien RG: Umthente uhlaba usamila: the 3rd South African national youth risk behaviour survey 2011. 2013.
    1. Levitt NS, Steyn K, Dave J, Bradshaw D. Chronic noncommunicable diseases and HIV-AIDS on a collision course: relevance for health care delivery, particularly in low-resource settings—insights from South Africa. Am J Clin Nutr. 2011;94(6):1690S–6S.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner